ALX Oncology Holdings Inc.ALXONASDAQ

Revenue (LTM)

Net Income (LTM)

$-102M

+24.6% YoY

Free Cash Flow

$-84M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-84	-127↓52.5%	-170↓33.6%	-142↑16.3%	-101↑29.2%
Net Income	-83	-123↓47.9%	-161↓30.2%	-135↑16.1%	-102↑24.6%
EBITDA	-83	-123↓47.3%	-158↓29.0%	-132↑16.5%	-101↑23.7%
EPS Diluted	-2.07	-3.03↓46.4%	-3.74↓23.4%	-2.58↑31.0%	-1.90↑26.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	364	49↓86.6%	22↓54.1%	18↓21.6%	16↓6.8%
Total Current Assets	367	271↓26.2%	189↓30.4%	134↓28.8%	51↓62.2%
Total Assets	380	306↓19.4%	243↓20.9%	148↓39.1%	59↓60.0%
Total Current Liabilities	15	28↑85.2%	36↑27.1%	19↓48.6%	25↑32.7%
Total Liabilities	17	43↑151.1%	53↑22.8%	34↓35.4%	33↓3.2%
Total Equity	363	263↓27.4%	190↓28.0%	114↓40.1%	26↓77.1%
Total Debt	1	10↑1305.7%	17↑64.9%	17↓1.3%	5↓69.3%
Net Debt	-363	-38↑89.4%	-5↑86.4%	-1↑88.7%	-11↓1794.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-68	-89↓31.0%	-130↓46.1%	-122↑6.5%	-84↑31.0%
Capital Expenditure	-5	-1↑71.0%	-1↑10.7%	-0↑64.9%	-0↑52.6%
Free Cash Flow	-73	-91↓24.1%	-132↓45.2%	-122↑7.0%	-84↑31.1%
Stock-Based Comp	14	24↑71.3%	26↑10.2%	27↑3.1%	13↓53.6%
Net Change in Cash	-71	-315↓346.2%	-26↑91.6%	-5↑81.7%	-1↑75.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance